Bioxytran (BIXT) Net Margin (2010 - 2018)
Bioxytran (BIXT) reported Net Margin of -1.35% for Q2 2018, up 658.40 percentage points from -659.75% a year earlier and up 3.68 percentage points from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Net Margin (2010 - 2018) Analysis & Trends
Over the twelve months ended Jun 30, 2018, Bioxytran's Net Margin came in at -21.64%, up 174.10 percentage points year-over-year; for FY2017, it came in at -166.63%, up 116.04 percentage points from FY2016.
- Net Margin has a five-year change of +566.27 percentage points (FY2012 to FY2017).
- By year, Net Margin came in at -282.67% in FY2016 (+538.27 pp), -820.93% in FY2015 (-332.25 pp), -488.69% in FY2014 (-62.52 pp) and -426.16% in FY2013 (+306.73 pp).
- Five-year quarterly Net Margin spans a low of -3225.60% in Q2 2015 and a high of 232.44% in Q4 2016.
- Year over year, Net Margin gained in four of the last seven quarters, with an average year-over-year change of +185.72 percentage points.
- The high point for year-over-year Net Margin in five years was Q3 2013 (a gain of 4411.90 percentage points); the low point was Q2 2015 (a drop of 3071.93 percentage points).
- Per Business Quant data, the three quarters before Q2 2018 came in at -5.03% (Q1 2018), -268.45% (Q4 2017) and 43.65% (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | -1.35% |
| Mar 31, 2018 | -5.03% |
| Dec 31, 2017 | -268.45% |
| Sep 30, 2017 | 43.65% |
| Jun 30, 2017 | -659.75% |
| Mar 31, 2017 | -868.56% |
| Dec 31, 2016 | 232.44% |
| Sep 30, 2016 | -211.58% |
| Jun 30, 2016 | -293.01% |
| Mar 31, 2016 | -1,443.43% |
| Sep 30, 2015 | -27.18% |
| Jun 30, 2015 | -3,225.60% |
| Mar 31, 2015 | -62.50% |
| Sep 30, 2014 | -2,689.92% |
| Jun 30, 2014 | -153.67% |
| Mar 31, 2014 | 30.13% |
| Dec 31, 2013 | 75.24% |
| Sep 30, 2013 | -497.70% |
| Jun 30, 2013 | -646.12% |
| Mar 31, 2013 | -852.20% |
API Access
Bioxytran Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();